Lumican is a potential predictor on the efficacy of concurrent chemoradiotherapy in cervical squamous cell carcinoma

Lumican is a potential predictor on the efficacy of concurrent chemoradiotherapy in cervical squamous cell carcinoma

Purpose: To identify new novel biomarkers for predicting the efficacy of concurrent chemoradiotherapy(CCRT) in cervical squamous cell carcinoma(CESC). Methods: Gene expression datasets GSE56363, GSE5787, and GSE168009 were analyzed to identify candidate genes to predict the efficacy of CCRT in CESC....

Full description

Bibliographic Details
Main Authors: Ge Hu, Ying Xiao, Chanchan Ma, Jinyun Wang, Xiaotao Qian, Xiaowei Wu, Fengqin Zhu, Shiying Sun, Junchao Qian
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Heliyon
Subjects:
CESC
LUM
CCRT
Biomarker
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023052192

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023052192

Similar Items